Main menu button

Actualités

Carlsquare advised SHD System-Haus-Dresden on its merger with Syserso Networks
06 Avr 2023
Carlsquare advised SHD System-Haus-Dresden on its merger with Syserso Networks
Deal News
Carlsquare advised Chatchamp on the sale to trbo, a portfolio company of Nordwind Growth
06 Avr 2023
Carlsquare advised Chatchamp on the sale to trbo, a portfolio company of Nordwind Growth
Deal News
Carlsquare advised the shareholders of TorAlarm on the sale of a majority stake to BILD, a subsidiary of Axel Springer
05 Avr 2023
Carlsquare advised the shareholders of TorAlarm on the sale of a majority stake to BILD, a subsidiary of Axel Springer
Deal News
Mrkt BUZZ Zinzino: Important Central Europe continues to deliver
05 Avr 2023
Mrkt BUZZ Zinzino: Important Central Europe continues to deliver
Equity Research Zinzino
Carlsquare weekly market letter: The worst may be over
05 Avr 2023
Carlsquare weekly market letter: The worst may be over
Equity Research Carlsquare
Carlsquare has merged with Silicon Valley-based tech investment bank Capital Clarity
04 Avr 2023
Carlsquare has merged with Silicon Valley-based tech investment bank Capital Clarity
Company News
Mrkt BUZZ ALM Equity: New owner in Klövern and upcoming new share issues
03 Avr 2023
Mrkt BUZZ ALM Equity: New owner in Klövern and upcoming new share issues
Equity Research ALM Equity
Research update Zazz Energy, Q4 2022: Possible upside in the stock, but significant risk
01 Avr 2023
Research update Zazz Energy, Q4 2022: Possible upside in the stock, but significant risk
Equity Research
First impression Zazz Energy, Q4 2022: Large write-downs and continued production standstill
31 Mar 2023
First impression Zazz Energy, Q4 2022: Large write-downs and continued production standstill
Equity Research
Mrkt BUZZ Risk Intelligence: The DHL deal, a great opportunity for upselling
30 Mar 2023
Mrkt BUZZ Risk Intelligence: The DHL deal, a great opportunity for upselling
Equity Research Risk Intelligence
Equity research Biosergen: Plans for speedy development of lead candidate
29 Mar 2023
Equity research Biosergen: Plans for speedy development of lead candidate
Equity Research Biosergen
Swedish Real Estate Equity Snapshot
29 Mar 2023
Swedish Real Estate Equity Snapshot
Equity Research
Carlsquare weekly market letter: Building energy, boiling and rotation beneath the surface
29 Mar 2023
Carlsquare weekly market letter: Building energy, boiling and rotation beneath the surface
Equity Research Carlsquare
Carlsquare advised F2 Healthcare in its acquisition by Meduit, expanding revenue cycle solutions for Medicare Bad Debt
24 Mar 2023
Carlsquare advised F2 Healthcare in its acquisition by Meduit, expanding revenue cycle solutions for Medicare Bad Debt
Deal News
Carlsquare weekly market letter: Are we back to 1929 or 2008?
22 Mar 2023
Carlsquare weekly market letter: Are we back to 1929 or 2008?
Equity Research Carlsquare
Initiation of coverage, Biosergen: Make antifungals great again
20 Mar 2023
Initiation of coverage, Biosergen: Make antifungals great again
Equity Research Biosergen
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
20 Mar 2023
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
Equity Research
Carlsquare weekly market letter: Tech rebounds as Fed trembles
15 Mar 2023
Carlsquare weekly market letter: Tech rebounds as Fed trembles
Equity Research Carlsquare
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
15 Mar 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
13 Mar 2023
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
Equity Research InCoax